Mechanistic exploration determined that curcumin can target miR-134-5p expression and regulate the CDCA3/CDK1 pathway, thereby inhibiting proliferation in CRC (Liu et al., 2023). The gene discussed is CDK1; the disease is colorectal carcinoma.